Internal Medicine, Pulmonary Disease · Columbia, MD
NPI
1235134370
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
10710 Charter Drive, Ste 310
Columbia, MD, 21044
Phone (410) 997-5944
Groups this clinician bills Medicare through
Medicare paid, 2024
$373K
5,691 services
Medicare patients, 2024
1,193
Average age 75
Drug cost, 2024
$2.1M
2,957 prescriptions
Company payments, 2025
$22K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David O Nyanjom was code 99214 (office e&m - established), 1,393 times for 753 patients. In total David O Nyanjom billed 5,691 services in 34 codes, and Medicare paid $373K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-10-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,393 | 753 | $91.75 | $128K |
| 99233 Hospital E&M - Subsequent | Facility | 584 | 213 | $89.55 | $52K |
| 99232 Hospital E&M - Subsequent | Facility | 458 | 161 | $58.46 | $27K |
| 94640 Treatment - Miscellaneous | Office | 410 | 325 | $5.98 | $2,450 |
| 94060 Pulmonary Function Testing | Office | 405 | 324 | $28.65 | $12K |
| 94664 E&M - Miscellaneous | Office | 402 | 322 | $13.12 | $5,275 |
| 99213 Office E&M - Established | Office | 375 | 274 | $63.55 | $24K |
| 94726 Pulmonary Function Testing | Office | 372 | 311 | $40.83 | $15K |
| 94729 Pulmonary Function Testing | Office | 351 | 295 | $40.79 | $14K |
| 99223 Hospital E&M - Initial | Facility | 299 | 261 | $129.05 | $39K |
| 99204 Office E&M - New | Office | 159 | 159 | $119.72 | $19K |
| 99215 Office E&M - Established | Office | 95 | 82 | $133.13 | $13K |
| 94010 Pulmonary Function Testing | Office | 94 | 81 | $18.71 | $1,759 |
| 94618 Pulmonary Function Testing | Office | 84 | 67 | $25.30 | $2,125 |
| 99205 Office E&M - New | Office | 61 | 61 | $154.87 | $9,447 |
By year: 2022 $281K for 3,882 services; 2023 $360K for 5,033 services; 2024 $373K for 5,691 services.
Medicare prescription drug claims, 2024
In 2024, the drug David O Nyanjom prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 322 prescriptions and refills. In total David O Nyanjom wrote 2,957 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 322 | 405 | 95 | $10K |
| Famotidine Generic | 319 | 653 | 107 | $4,233 |
| Montelukast Sodium Generic | 313 | 736 | 89 | $4,491 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 249 | 401 | 57 | $252K |
| Pantoprazole Sodium Generic | 210 | 391 | 80 | $2,174 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 118 | 160 | 37 | $97K |
| Fluticasone Propionate Generic | 105 | 187 | 42 | $2,024 |
| Breo Ellipta Fluticasone/Vilanterol | 90 | 185 | 27 | $71K |
| Prednisone Generic | 89 | 109 | 37 | $688 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 82 | 146 | 24 | $65K |
| Ventolin Hfa Albuterol Sulfate | 62 | 72 | 17 | $4,671 |
| Quetiapine Fumarate Generic | 56 | 100 | 17 | $552 |
| Azelastine Hcl Generic | 51 | 97 | 18 | $2,242 |
| Aralast Np Alpha-1-Proteinase Inhibitor | 40 | 40 | Under 11 | $396K |
| Azelastine-Fluticasone Azelastine/Fluticasone | 37 | 47 | 16 | $3,253 |
Brand drugs: - claims; generic drugs: 1,723 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David O Nyanjom $22K ($22K in general payments such as food, travel and fees) from 17 companies. The largest payer was Verona Pharma, Inc. with $18K.
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. VRNA | 26 | $18K |
| AstraZeneca Pharmaceuticals LP AZN | 25 | $538 |
| GlaxoSmithKline, LLC. GSK | 23 | $532 |
| Mallinckrodt Hospital Products Inc. | 13 | $445 |
| Viatris Specialty LLC | 18 | $384 |
| Grifols USA, LLC | 10 | $322 |
| Regeneron Healthcare Solutions, Inc. REGN | 9 | $251 |
| Genzyme Corporation SNY | 9 | $218 |
| Insmed, Inc. INSM | 10 | $162 |
| Vifor Pharma, Inc. | 7 | $160 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.